InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Romulus K Brazzell, a SEE REMARKS, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $174K, reported from Oct 26, 21 to Oct 22, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 22, 25 | KALAKALA BIO, Inc. | SELL | 46.7K | $0.83 | $39K |
| Jun 24, 25 | KALAKALA BIO, Inc. | SELL | 5.3K | $4.01 | $21K |
| Jun 3, 25 | KALAKALA BIO, Inc. | SELL | 3.7K | $3.74 | $14K |
| Jan 6, 25 | KALAKALA BIO, Inc. | SELL | 2.4K | $7.63 | $19K |
| Jun 26, 24 | KALAKALA BIO, Inc. | SELL | 5.5K | $4.75 | $26K |
| May 31, 24 | KALAKALA BIO, Inc. | SELL | 2.0K | $6.09 | $12K |
| Jan 4, 24 | KALAKALA BIO, Inc. | SELL | 1.6K | $6.74 | $11K |
| Jan 4, 23 | KALAKala Pharmaceuticals, Inc. | SELL | 73 | $28.53 | $2K |
| Oct 26, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 261 | $6.51 | $2K |
| Jun 27, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 3.1K | $0.37 | $1K |
| Jan 4, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 3.5K | $1.30 | $5K |
| Oct 26, 21 | KALAKala Pharmaceuticals, Inc. | SELL | 12.8K | $1.80 | $23K |